Related Experiment Video
Updated: Aug 24, 2025

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Cognitive Impairment in Tuberculous Meningitis
Angharad G Davis1,2,3, Anna J Dreyer4, Christine Albertyn5,6
1The Francis Crick Institute, London, United Kingdom.
Cognitive impairment is common after tuberculous meningitis (TBM) in adults with HIV, affecting all cognitive domains. This impairment is distinct from HIV or non-central nervous system tuberculosis effects.
Area of Science:
- Neuroscience
- Infectious Diseases
- Public Health
Background:
- Cognitive impairment is a frequent complication of adult tuberculous meningitis (TBM).
- Limited research systematically assesses the frequency and characteristics of TBM-related cognitive deficits.
- The impact of cognitive impairment on daily functioning and medication adherence in TBM patients remains under-described.
Purpose of the Study:
- To systematically assess the frequency and nature of cognitive impairment in adults with HIV-associated TBM.
- To compare cognitive performance in TBM patients with HIV-only and HIV with non-CNS tuberculosis controls.
- To evaluate the impact of cognitive impairment on functioning and medication adherence.
Main Methods:
- Administered a cognitive test battery (10 measures, 7 domains) to 34 participants with HIV-associated TBM 6 months post-diagnosis.
- Compared cognitive performance with 66 individuals with HIV without tuberculosis history and 26 with HIV and non-CNS tuberculosis.
- Assessed functional outcomes and medication adherence in a subgroup of participants.
Main Results:
- 47% of TBM participants (16 of 34) exhibited low cognitive performance across all assessed domains.
- TBM patients showed significantly lower global cognitive performance compared to HIV-only controls (mean T score 41 vs 48, P < .001).
- TBM patients also had lower global cognition than those with non-CNS tuberculosis (mean T score 41 vs 46, P = .02).
Conclusions:
- Low cognitive performance is a common sequela of HIV-associated TBM, independent of HIV or non-CNS tuberculosis.
- Further research is needed to understand long-term outcomes and the relationship between cognitive function and treatment adherence.
- Development of context-specific tools is crucial for identifying and managing cognitive difficulties in TBM patients to improve outcomes.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:35Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
Published on: May 19, 2020
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...